跳至主要内容
临床试验/NCT02232503
NCT02232503已完成不适用

DIARET SK - Prevalence of Diabetic Retinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in Slovakia

Novartis Slovakia, s.r.o.0 个研究点目标入组 4,011 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
4,011
主要终点
The prevalence of diabetic retinopathy as the proportion of patients with DR (any stage) in a given subgroup according to DM duration

研究概览

简要总结

The aim of the study is to find out prevalence and individual stages of Diabetic Retinopathy in patients with type 1 and type 2 DM verified based on complex ophthalmologic measurements in Slovak Republic. The outcome of the project will be epidemiology survey, prevalence of diabetic retinopathy (DR) and diabetic macular edema (DME) in relation to type and duration of diabetes mellitus and risk factors. Project will also identify genetic factors linked with the diseases.

研究设计

研究类型
Observational
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Signed informed consent for epidemiological research
  • Signed informed consent for genetic research
  • Patients with DM - type I and II regardless of the DM duration
  • All DM patients must be included regardless of presence of eye complications in patient´s anamnesis or during the examination by the diabetologist Subgroups analysis
  • Patients with DM - type I and II and DM duration ≥ 20 years
  • Patients with DM - type I and II and DM duration < 5 years and DR in history

排除标准

  • Age at the time of inclusion into the <18 years
  • Gestational DM or secondary-induced diabetes
  • Diabetic ketoacidosis or hyperosmolar coma
  • Alcohol abuse or acute alcohol intoxication

结局指标

主要结局

The prevalence of diabetic retinopathy as the proportion of patients with DR (any stage) in a given subgroup according to DM duration

时间窗: participants screened each working day within 8 working hours during a 6 months period in selected diabetology centers according to protocol criteria

The results will be accompanied by Wald 95% confidence intervals. The combined prevalence results from more subgroups will be evaluated using weighted average using the best available epidemiology data.

次要结局

  • Evaluate the prevalence and individual stages of Diabetic Retinopathy in patients with type 1 and type 2 DM verified based on complex ophthalmologic measurements(participants screened each working day within 8 working hours during a 6 months period in selected diabetology centers according to protocol criteria)
  • Evaluate the prevalence and individual stages of Diabetic Macular Edema (DME) in patients with type 1 and type 2 DM verified based on complex ophthalmologic measurements(participants screened each working day within 8 working hours during a 6 months period in selected diabetology centers according to protocol criteria)
  • Evaluate the impact of risk factors on the prevalence of Diabetic Retinopathy and Diabetic Macular Edema(participants screened each working day within 8 working hours during a 6 months period in selected diabetology centers according to protocol criteria)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Prevalence of DIAbetic RETinopathy and Impact of... | 临床试验